BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28606014)

  • 21. Monoclonal antibodies to detect capsular diversity among Bacteroides fragilis isolates.
    Pantosti A; Colangeli R; Tzianabos AO; Kasper DL
    J Clin Microbiol; 1995 Oct; 33(10):2647-52. PubMed ID: 8567899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular immunity to Bacteroides fragilis capsular polysaccharide.
    Shapiro ME; Onderdonk AB; Kasper DL; Finberg RW
    J Exp Med; 1982 Apr; 155(4):1188-97. PubMed ID: 6174672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The
    Parker AC; Bergonia HA; Seals NL; Baccanale CL; Rocha ER
    Infect Immun; 2020 Jul; 88(8):. PubMed ID: 32457103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model.
    Kasper DL; Onderdonk AB
    Scand J Infect Dis Suppl; 1982; 31():28-33. PubMed ID: 6954635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a Fifth Antibacterial Toxin Produced by a Single Bacteroides fragilis Strain.
    Shumaker AM; Laclare McEneany V; Coyne MJ; Silver PA; Comstock LE
    J Bacteriol; 2019 Apr; 201(8):. PubMed ID: 30692177
    [No Abstract]   [Full Text] [Related]  

  • 26. TLR2 and interleukin-10 are involved in Bacteroides fragilis-mediated prevention of DSS-induced colitis in gnotobiotic mice.
    Chang YC; Ching YH; Chiu CC; Liu JY; Hung SW; Huang WC; Huang YT; Chuang HL
    PLoS One; 2017; 12(7):e0180025. PubMed ID: 28683149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model.
    Onderdonk AB; Markham RB; Zaleznik DF; Cisneros RL; Kasper DL
    J Clin Invest; 1982 Jan; 69(1):9-16. PubMed ID: 6976357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A paradigm for commensalism: the role of a specific microbial polysaccharide in health and disease.
    Kasper DL
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():1-8; discussion 8-10, 251-7. PubMed ID: 19710511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a gene cluster for sialoglycoconjugate utilization in Bacteroides fragilis.
    Nakayama-Imaohji H; Ichimura M; Iwasa T; Okada N; Ohnishi Y; Kuwahara T
    J Med Invest; 2012; 59(1-2):79-94. PubMed ID: 22449996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of rep-PCR to define genetic relatedness among Bacteroides fragilis strains.
    Moraes SR; Gonçalves RB; Mouton C; Seldin L; Ferreira MCS; Domingues RMCP
    J Med Microbiol; 2000 Mar; 49(3):279-284. PubMed ID: 10707948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel large-scale chromosomal transfer in Bacteroides fragilis contributes to its pan-genome and rapid environmental adaptation.
    Husain F; Tang K; Veeranagouda Y; Boente R; Patrick S; Blakely G; Wexler HM
    Microb Genom; 2017 Nov; 3(11):. PubMed ID: 29208130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virulence factors in Bacteroides fragilis group.
    Jotwani R; Gupta U
    Indian J Med Res; 1991 Jul; 93():232-5. PubMed ID: 1959952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative determination of the serum antibody response to the capsular polysaccharide of Bacteroides fragilis subspecies fragilis in women with pelvic inflammatory disease.
    Kasper DL; Eschenbach DA; Hayes ME; Holmes KK
    J Infect Dis; 1978 Jul; 138(1):74-80. PubMed ID: 98597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis.
    Kasper DL; Onderdonk AB; Crabb J; Bartlett JG
    J Infect Dis; 1979 Nov; 140(5):724-31. PubMed ID: 528789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological detection of Bacteroides fragilis in clinical samples.
    Patrick S; Stewart LD; Damani N; Wilson KG; Lutton DA; Larkin MJ; Poxton I; Brown R
    J Med Microbiol; 1995 Aug; 43(2):99-109. PubMed ID: 7629860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding and degradation of fibrinogen by Bacteroides fragilis and characterization of a 54 kDa fibrinogen-binding protein.
    Houston S; Blakely GW; McDowell A; Martin L; Patrick S
    Microbiology (Reading); 2010 Aug; 156(Pt 8):2516-2526. PubMed ID: 20466764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of a capsular polysaccharide biosynthesis locus of Bacteroides fragilis.
    Comstock LE; Coyne MJ; Tzianabos AO; Pantosti A; Onderdonk AB; Kasper DL
    Infect Immun; 1999 Jul; 67(7):3525-32. PubMed ID: 10377135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a collagen type I adhesin of Bacteroides fragilis.
    Galvão BP; Weber BW; Rafudeen MS; Ferreira EO; Patrick S; Abratt VR
    PLoS One; 2014; 9(3):e91141. PubMed ID: 24618940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the outer membrane proteome and secretome of Bacteroides fragilis reveals a multiplicity of secretion mechanisms.
    Wilson MM; Anderson DE; Bernstein HD
    PLoS One; 2015; 10(2):e0117732. PubMed ID: 25658944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacteroides fragilis-stimulated interleukin-10 contains expanding disease.
    Cohen-Poradosu R; McLoughlin RM; Lee JC; Kasper DL
    J Infect Dis; 2011 Aug; 204(3):363-71. PubMed ID: 21742834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.